Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ARTERIAL VASCULAR ENGINEERING -- Ignore unavailable to you. Want to Upgrade?

To: B4TheBell who wrote (328)	1/10/1998 8:57:00 PM
From: bullw	Respond to of 339

Some of you who follow AVE may be able to tell me if other companies have stents of comparable quality in the FDA pipeline? I understand that by summer other products will be competitive. Maybe this accounts for the discounting of the price and the insider trading. My fear is that this stock is gaining momentum to the downside. Any information would be greatly appreciated.

To: B4TheBell who wrote (328)	1/12/1998 3:48:00 PM
From: Jeff Gurian	Respond to of 339

I pretty much agree with what you say. If you look at some of my previous posts I have also noted the growth concern for AVE. I have also stated that I do not see myself holding this stock much past the middle of the year because of lack of growth. My guess is that the company will have two stellar quarters where they blow away earnings expectations. After two quarters, though, either 1. analysts will get wise and revise their expected earnings numbers or 2. AVE sales will begin to slow. After all, how many stents can they hope to sell and who do they expect to keep selling to over the next few years? Because AVE did not get approval until late Dec, I dont expect much from their next earnings report. The quarter after that, though, should be huge. Thats probably when Ill bail out. I already bought some more of AVE in the low 50's- this is an attractive time to buy (mabye). Im just going to sit tight for now.